Acute Kidney Injury After Liver Transplantation

  • Raymond M. Planinsic
  • Tetsuro Sakai
  • Ibtesam A. Hilmi


The incidence of postoperative renal insufficiency and acute kidney injury (AKI) in patients undergoing liver transplantation ranges from 20 % up to 90 % [1] and more than 80 % of these episodes occur within the first 2 postoperative days. Earlier studies found that mortality at 30 days was 50 % in patients who developed AKI and 29 % in non-AKI patients [2]. AKI necessitating renal replacement therapy has been associated with mortality rates from 55 to 90 % [3]. Risk factors for the development of AKI in these patients include preoperative renal dysfunction represented with a higher preoperative serum creatinine (SCrea), greater requirements for intraoperative blood transfusion, more frequent episodes of intraoperative hypotension, and other preexisting comorbidities [2].


Liver Transplantation Renal Replacement Therapy Acute Kidney Injury Renal Injury Hemolytic Uremic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    McCauley J, et al. Acute and chronic renal failure in liver transplantation. Nephron. 1990;55(2):121–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Pascual E, et al. Incidence and risk factors of early acute renal failure in liver transplant patients. Transplant Proc. 1993;25(2):1827.Google Scholar
  3. 3.
    Ishitani M, et al. Outcome of patients requiring hemodialysis after liver transplantation. Transplant Proc. 1993;25(2):1762–3.PubMedGoogle Scholar
  4. 4.
    Bellomo R, et al. Acute Dialysis Quality Initiative workgroup. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12.PubMedCrossRefGoogle Scholar
  5. 5.
    Mehta RL, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.PubMedCrossRefGoogle Scholar
  6. 6.
    Fraley DS, et al. Impact of acute renal failure on mortality in end-stage liver disease with or without transplant. Kidney Int. 1998;54:518–24.PubMedCrossRefGoogle Scholar
  7. 7.
    Wagener G, et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrol Dial Transplant. 2011;26(5):1717–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Niemann CU, et al. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl. 2009;15(12):1852–60.PubMedCrossRefGoogle Scholar
  9. 9.
    Portal AJ, et al. Neutrophil gelatinase-associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transpl. 2010;16(11):1257–66.PubMedCrossRefGoogle Scholar
  10. 10.
    Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med. 2002;137(9):744–52.PubMedGoogle Scholar
  11. 11.
    Cotterell AH, et al. Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent. Clin Transpl. 2002;16 Suppl 7:49–51.CrossRefGoogle Scholar
  12. 12.
    Gonwa TA, et al. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Transplantation. 2002;74(11):1560–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Benigni A, et al. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int. 1999;55(2):674–85.PubMedCrossRefGoogle Scholar
  14. 14.
    Jurewicz WA, et al. Tracolimus versus cyclosporine immunosuppression: long-term outcome in renal transplantation. Nephrol Dial Transplant. 2003;18 Suppl 1:I7–11.PubMedCrossRefGoogle Scholar
  15. 15.
    Starzl TE, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361(9368):1502–10.PubMedCrossRefGoogle Scholar
  16. 16.
    Cardarelli F, et al. The problem of late allograft loss in kidney transplantation. Minerva Urol Nefrol. 2003;55(1):1–11.PubMedGoogle Scholar
  17. 17.
    Ojo AO, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(10):931–40.PubMedCrossRefGoogle Scholar
  18. 18.
    Rerolle JP, et al. Tacrolimus-induced hemolytic uremic syndrome and end stage renal failure after liver transplantation. Clin Transplant. 2000;14(3):262–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Evens AM, et al. TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology. Transplantation. 2002;74(6):885–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Yango A, et al. Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange. Clin Nephrol. 2002;58(1):77–8.PubMedGoogle Scholar
  21. 21.
    Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenia purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2001;8(5):286–93.PubMedCrossRefGoogle Scholar
  22. 22.
    Holman MJ, et al. FK506 associated thrombotic thrombocytopenic purpura. Transplantation. 1993;55(1):205–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Burch J, Moore F, Franciose R. The abdominal compartment syndrome. Surg Clin North Am. 1996;76:833–42.PubMedCrossRefGoogle Scholar
  24. 24.
    Malbrain M. Abdominal pressure in the critically ill patients. Intensive Care Med. 1999;25:1453–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Cullen DJ, et al. Cardiovascular, pulmonary and renal effects of massively increased intra-abdominal pressure in critically ill patients. Crit Care Med. 1989;17:118–21.PubMedCrossRefGoogle Scholar
  26. 26.
    Biancofiore G, et al. Intra-abdominal pressure monitoring in liver transplant recipients: a prospective study. Intensive Care Med. 2003;29(1):30–6.PubMedGoogle Scholar
  27. 27.
    Mogilner J, et al. Effect of elevated intra-abdominal pressure on portal vein and superior mesenteric artery blood flow in a rat. J Laparoendosc Adv Surg Tech A. 2009;19 Suppl 1:S59–62.PubMedCrossRefGoogle Scholar
  28. 28.
    Tsai JD, et al. Epstein-Barr virus-associated acute renal failure: diagnosis, treatment and follow-up. Pediatr Nephrol. 2003;18(7):667–74.PubMedGoogle Scholar
  29. 29.
    Collins MH, et al. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder. Pediatrics. 2001;107(6):E89.PubMedCrossRefGoogle Scholar
  30. 30.
    Iwamoto S, et al. BK virus-associated fatal renal failure following late-onset hemorrhagic cystitis in an unrelated bone marrow transplant. Pediatr Hematol Oncol. 2002;19(4):255–61.PubMedCrossRefGoogle Scholar
  31. 31.
    Hirsch HH, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488–96.PubMedCrossRefGoogle Scholar
  32. 32.
    Elli A, et al. BK polyomavirus interstitial nephritis in a renal transplant patient with no previous acute rejection episodes. J Nephrol. 2002;15(3):313–6.PubMedGoogle Scholar
  33. 33.
    Hirsch HH, et al. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant. 2002;2(1):25–30.PubMedCrossRefGoogle Scholar
  34. 34.
    Marshall WF, et al. Survey of urine from transplant recipients for polyomavirus JC and BK using the polymerase chain reaction. Mol Cell Probes. 1991;5(2):125–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Raymond M. Planinsic
    • 1
  • Tetsuro Sakai
    • 2
  • Ibtesam A. Hilmi
    • 3
  1. 1.Department of AnesthesiologyUniversity of Pittsburgh Medical CenterPittsburghUSA
  2. 2.Department of AnesthesiologyUniversity of Pittsburgh School of MedicinePittsburghUSA
  3. 3.Department of AnesthesiologyUPMC PresbyterianPittsburghUSA

Personalised recommendations